1 / 8

Pre-menstrual Syndrome Treatment Market by Drug, by Geography, Size, Share, Growth, Global Trends, Industry Analysis an

the CAGR of over 3%u00a0market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019.u00a0The global pre-menstrual syndrome treatment market is segmented by drug type as analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants,u00a0ovarianu00a0suppressors, diuretics, and benzodiazepines. Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market

purushottamrajput786
Download Presentation

Pre-menstrual Syndrome Treatment Market by Drug, by Geography, Size, Share, Growth, Global Trends, Industry Analysis an

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pre-menstrual Syndrome Treatment Market Know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=144540 Pre-menstrual Syndrome Treatment Market by Drug, by Geography, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

  2. Global Pre-menstrual Syndrome Treatment Market Market Synopsis: Theglobal pre-menstrual syndrome treatment market size is projected to grow at the CAGR of over 3% market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019. The global pre-menstrual syndrome treatment market is segmented by drug type as analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants, ovarian suppressors, diuretics, and benzodiazepines. Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market

  3. Global Pre-menstrual Syndrome Treatment Market Research Methoddolgy:

  4. Global Pre-menstrual Syndrome Treatment Market Global Pre-menstrual Syndrome Treatment Market Segmentation: By  Drug Type, 2018–2027 ($ Millon) • Analgesics (pain killers) • Oral Contraceptive Pills (OCPs) • Gonadotropin-releasing Hormone (GnRH) • Antidepressants • Ovarian Suppressors • Diuretics • Benzodiazepines

  5. Global Pre-menstrual Syndrome Treatment Market Global Pre-menstrual Syndrome Treatment Market Segmentation: By Geography, 2018-2027 ($ Millon) • North America • Europe • Asia Pacific • Latin America (LATAM) • Middle East and Africa (MEA)

  6. Global Pre-menstrual Syndrome Treatment Market List of Key Companies: • Alva-AmcoPharmacal Cos., Inc. • Bayer, Inc. • Chattem, Inc. (Sanofi) • DEKK-TEC, Inc. • R. Lane Health Products Ltd • McNeil Consumer Healthcare • MetPPharma AG • Pherin Pharmaceuticals, Inc. • Umecrine Mood AB • Novartis AG • GlaxoSmithKline Plc

  7. Global Pre-menstrual Syndrome Treatment Market By Region:

  8. Global Pre-menstrual Syndrome Treatment Market Media Contact: Company Name: Research CorridorContact Person: Mr. Vijendra SinghEmail: sales@researchcorridor.comContact no: +91 989-368-5690 Follow Us:

More Related